| Characteristics | Control () | T2DM () | value |
| Sex, men (%) | 27 (45.8%) | 104 (55.0%) | 0.214 | Age, y | | | <0.001 | BMI (kg/m2) | 23.20 (21.30, 25.39) | 25.17 (22.93, 27.35) | <0.001 | WC (cm) | | | <0.001 | HC (cm) | 96.00 (92.20, 100.50) | 96.00 (92.00, 100.50) | 0.805 | WHR | 0.87 (0.82, 0.92) | 0.94 (0.90, 0.97) | <0.001 | Duration of T2DM (M) | — | 48.00 (1.00, 126.00) | — | Hypertension, (%) | 4 (6.8%) | 90 (47.6%) | <0.001 | SBP (mmHg) | 118.00 (106.00, 126.00) | 132 (122.00, 146.00) | <0.001 | DBP (mmHg) | 68.00 (61.00, 78.00) | 81.00 (75.00, 89.00) | <0.001 | Smoking, (%) | 15 (25.4%) | 45 (23.8%) | 0.801 | ACEI/ARB use | — | 59 (31.2%) | — | Statins use | — | 4 (2.1%) | — | Insulin | — | 57 (30.2%) | — | Oral agents | — | 65 (34.4%) | — | Insulin+oral agents | — | 31 (16.4%) | — | FPG (mmol/L) | 4.60 (4.26, 5.04) | 9.95 (7.94, 12.76) | <0.001 | 2hPG (mmol/L) | 6.36 (5.77, 6.91) | 19.05 (15.91, 22.90) | <0.001 | FIns (μIU/mL) | 4.62 (2.73, 6.56) | 7.41 (4.60, 11.84) | <0.001 | 2hIns (μIU/mL) | 26.99 (18.58, 43.56) | 28.30 (16.47, 52.38) | 0.577 | FC-P (ng/mL) | | | 0.058 | 2hCP(ng/mL) | 7.78 (5.75, 9.64) | 4.62 (3.11, 6.78) | <0.001 | Hb1Ac (%) | 5.70 (5.60, 5.90) | 9.30 (8.05, 11.00) | <0.001 | HOMA-IR | 0.95 (0.56, 1.35) | 3.53 (2.17, 4.93) | <0.001 | HOMA-β | 77.02 (46.49, 135.73) | 22.70 (11.82, 45.22) | <0.001 | TG (mmol/L) | 1.30 (0.90, 1.77) | 1.93 (1.36, 2.98) | <0.001 | TC (mmol/L) | 4.92 (4.50, 5.51) | 4.94 (4.21, 5.91) | 0.673 | LDL-C (mmol/L) | 2.66 (2.34, 3.30) | 2.81 (2.33, 3.65) | 0.229 | HDL-C (mmol/L) | 1.41 (1.19, 1.69) | 1.07 (0.90, 1.27) | <0.001 | ALT (U/L) | 15.40 (9.80, 28.90) | 22.00 (13.55, 38.05) | 0.014 | AST (U/L) | 17.10 (13.70, 21.60) | 17.40 (12.95, 26.50) | 0.998 | UA (μmol/L) | | | 0.325 | BUN (mmol/L) | 4.70 (4.14, 5.83) | 5.19 (4.33, 6.08) | 0.045 | Creatinine (μmol/L) | 66 (58.80, 75.20) | 57.80 (47.95, 69.45) | 0.001 | eGFR(mL/[min1.73m2]) | 103.20 (92.50, 111.60) | 110.57 (96.15, 126.20) | 0.030 | EDA | 268.72 (218.31, 331.61) | 337.47263.89, 407.00) | <0.001 |
|
|